Mouse model of chronic and binge ethanol feeding (the NIAAA model)

Nature Protocols

Volumn 8, Issue 3, 2013, Pages 627-637

  Bertola, Adeline ^a   Mathews, Stephanie ^a   Ki, Sung Hwan ^a   Wang, Hua ^a   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; FATTY LIVER; FEMALE; HEPATITIS; LIVER HISTOLOGY; LIVER INJURY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; WEIGHT GAIN;

ALCOHOLISM; ANIMALS; BINGE DRINKING; DISEASE MODELS, ANIMAL; ETHANOL; LIVER DISEASES, ALCOHOLIC; MALE; MICE; MICE, INBRED C57BL; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (U.S.); UNITED STATES;

EID: 84875160269     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2013.032     Document Type: Article

References (44)

1. Gao, B. & Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572-1585 (2011).
2. Tsukamoto, H. & Lu, S.C. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J. 15, 1335-1349 (2001).
3. O'Shea, R.S., Dasarathy, S. & McCullough, A.J. Practice Guideline Committee of the American Association for the Study of Liver, D. & Practice Parameters Committee of the American College of, G. Alcoholic liver disease. Hepatology 51, 307-328 (2010).
4. Stickel, F. & Seitz, H.K. Alcoholic steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 24, 683-693 (2010).
5. Beier, J.I., Arteel, G.E. & McClain, C.J. Advances in alcoholic liver disease. Curr. Gastroenterol. Rep. 13, 56-64 (2011).
6. Bellentani, S. et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 41, 845-850 (1997).
7. Stranges, S. et al. Differential effects of alcohol drinking pattern on liver enzymes in men and women. Alcohol. Clin. Exp. Res. 28, 949-956 (2004).
8. Li, T.K. Quantifying the risk for alcohol-use and alcohol-attributable health disorders: present findings and future research needs. J. Gastroenterol. Hepatol. 23 (suppl. 1), S2-S8 (2008).
9. Ki, S.H. et al. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52, 1291-1300 (2010).
10. Mathurin, P. & Lucey, M.R. Management of alcoholic hepatitis. J. Hepatol. 56 (suppl. 1), S39-S45 (2012).
11. Choi, G. & Runyon, B.A. Alcoholic hepatitis: a clinician's guide. Clin. Liver Dis. 16, 371-385 (2012).
12. Altamirano, J. & Bataller, R. Alcoholic liver disease: pathogenesis and new targets for therapy. Nat. Rev. Gastroenterol. and Hepatol. 8, 491-501 (2011).
13. Aroor, A.R., Jackson, D.E. & Shukla, S.D. Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats. Alcohol. Clin. Exp. Res. 35, 2128-2138 (2011).
14. Petrasek, J. et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J. Clin. Invest. 122, 3476-3489 (2012).
15. Cohen, J.I., Roychowdhury, S., McMullen, M.R., Stavitsky, A.B. & Nagy, L.E. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology 139, 664-674 (2010).
16. Mandrekar, P., Ambade, A., Lim, A., Szabo, G. & Catalano, D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 54, 2185-2197 (2011).
17. Nath, B. et al. Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 53, 1526-1537 (2011).
18. Hu, M. et al. Regulation of hepatic lipin-1 by ethanol: role of AMP-activated protein kinase/sterol regulatory element-binding protein 1 signaling in mice. Hepatology 55, 437-446 (2012).
19. Liangpunsakul, S. et al. Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed mice. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G515-523 (2012).
20. Leung, T.M. et al. Argininosuccinate synthase conditions the response to acute and chronic ethanol-induced liver injury in mice. Hepatology 55, 1596-1609 (2012).
21. Zhou, Z. et al. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am. J. Pathol. 166, 1681-1690 (2005).
22. Ueno, A. et al. Mouse intragastric infusion (iG) model. Nat. Protoc. 7, 771-781 (2012).
23. Xu, J. et al. Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J. Hepatol. 55, 673-682 (2011).
24. Tsukamoto, H. et al. Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology 5, 224-232 (1985).
25. Kisseleva, T. et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc. Natl. Acad. Sci. USA 109, 9448-9453 (2012).
26. Zhou, Z. et al. A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-α production. Am. J. Pathol. 163, 1137-1146 (2003).
27. Zhou, Z., Sun, X. & James Kang, Y. Metallothionein protection against alcoholic liver injury through inhibition of oxidative stress. Exp. Biol. Med. 227, 214-222 (2002).
28. Beier, J.I., Kaiser, J.P., Guo, L., Martinez-Maldonado, M. & Arteel, G.E. Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis. Arch. Biochem. Biophys. 510, 19-26 (2011).
29. Kao, E., Shinohara, M., Feng, M., Lau, M.Y. & Ji, C. Human immunodeficiency virus protease inhibitors modulate Ca2+ homeostasis and potentiate alcoholic stress and injury in mice and primary mouse and human hepatocytes. Hepatology 56, 594-604 (2012).
30. Cook, R.T. et al. Thymocytes, pre-B cells, and organ changes in a mouse model of chronic ethanol ingestion-absence of subset-specific glucocorticoid-induced immune cell loss. Alcohol. Clin. Exp. Res. 31, 1746-1758 (2007).
31. Meadows, G.G., Blank, S.E. & Duncan, D.D. Influence of ethanol consumption on natural killer cell activity in mice. Alcohol. Clin. Exp. Res. 13, 476-479 (1989).
32. Coleman, R.A., Young, B.M., Turner, L.E. & Cook, R.T. A practical method of chronic ethanol administration in mice. Methods Mol. Biol. 447, 49-59 (2008).
33. Brandon-Warner, E., Schrum, L.W., Schmidt, C.M. & McKillop, I.H. Rodent models of alcoholic liver disease: Of mice and men. Alcohol 46, 715-725 (2012).
34. Brandon-Warner, E., Walling, T.L., Schrum, L.W. & McKillop, I.H. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol. Clin. Exp. Res. 36, 641-653 (2012).
35. Gabele, E. et al. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. Alcohol. Clin. Exp. Res. 35, 1361-1367 (2011).
36. Wei, V.L. & Singh, S.M. Genetically determined response of hepatic aldehyde dehydrogenase activity to ethanol exposures may be associated with alcohol sensitivity in mouse genotypes. Alcohol. Clin. Exp. Res. 12, 39-45 (1988).
37. You, M., Considine, R.V., Leone, T.C., Kelly, D.P. & Crabb, D.W. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 42, 568-577 (2005).
38. Everitt, H. et al. Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G38-G47 (2013).
39. Tsuchiya, M. et al. Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice. Hepatology 56, 130-139 (2012).
40. Butura, A. et al. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J. Hepatol. 50, 572-583 (2009).
41. Lu, Y., Zhuge, J., Wang, X., Bai, J. & Cederbaum, A.I. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 47, 1483-1494 (2008).
42. Kono, H. et al. Gender differences in early alcohol-induced liver injury: role of CD14, NF-κB, and TNF-α. Am. J. Physiol. Gastrointest. Liver Physiol. 278, G652-G661 (2000).
43. Nanji, A.A. et al. Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G1348-G1356 (2001).
44. Kirpich, I.A. et al. The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. Alcohol. Clin. Exp. Res. 36, 835-846 (2012).